Clinical Trial Update: Efficacy and Safety of Oral Administration of Postibiotic by FOS Fermentation From Lactobacillus Paracasei in the Treatment of Irritable Bowel Syndrome. [NA]

View source ↗

Summary

A clinical trial update describing an oral probiotic formulation (Postibiotic) derived from FOS-fermented Lactobacillus paracasei for irritable bowel syndrome, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Postibiotic (FOS-fermented Lactobacillus paracasei formulation)

Snippet

Sponsor: Istituto Clinico Humanitas | Conditions: IBS - Irritable Bowel Syndrome | NA | Status: NOT_YET_RECRUITING